You have 9 free searches left this month | to do more

Lenalidomide

Lenalidomide is a drug used to treat Multiple Myeloma, Chronic Lymphocytic Leukemia, Lymphoma, and other conditions. Lenalidomide is being actively studied in 274 studies and prior, has been studied in 253.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterMayo ClinicIrene Ghobrial, MD
National Cancer Institute (NCI)Washington University School of MedicineJacob Laubach
CelgeneDana-Farber Cancer InstituteZhao Weili
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
A
Active, not recruiting
  • Lymphoma
  • Lenalidomide
  • Philadelphia, Pennsylvania
    Jakub Svoboda
2021-10-04
Oct 4, 2021
S
Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
2021-08-20
Aug 20, 2021
U
Active, not recruiting
  • Multiple Myeloma
  • Lenalidomide
  • +3 more
  • Chicago, Illinois
  • +2 more
2021-06-29
Jun 29, 2021
W
Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
2021-05-13
May 13, 2021
H
Recruiting
  • Central Nervous System Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib
  • +2 more
  • Zhengzhou, Henan, China
    Henan cancer hospital
2021-06-16
Jun 16, 2021
M
Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Lenalidomide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2021-07-13
Jul 13, 2021
N
Completed
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Lenalidomide
  • XRT, 54-59.4 Gy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-10-23
Oct 23, 2021
H
Completed
  • Multiple Myeloma
  • Lenalidomide
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-10-08
Oct 8, 2021
U
Active, not recruiting
  • Lymphoma
  • Rituximab
  • Lenalidomide
  • Sacramento, California
    University of California Davis Cancer Center
2021-02-04
Feb 4, 2021
B
Not yet recruiting
  • Relapsed/Refractory Marginal Zone Lymphoma
  • (no location specified)
2021-10-21
Oct 21, 2021
B
Recruiting
  • EBV Infection
  • PD1 antibody
  • lenalidomide
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
2021-06-27
Jun 27, 2021
W
Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
2021-09-02
Sep 2, 2021
H
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-08-15
Aug 15, 2021
U
Active, not recruiting
  • Richter's Syndrome
  • CLL
  • La Jolla, California
    University of California, San Diego
2021-04-08
Apr 8, 2021
T
Completed
  • Relapsed and/or Refractory Multiple Myeloma
  • Tokyo, Japan
    Takeda Selected Site
2021-06-03
Jun 3, 2021
M
Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-08
Nov 8, 2021
F
Active, not recruiting
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
2021-11-02
Nov 2, 2021
S
Recruiting
  • Primary Central Nervous System Lymphoma
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
2021-06-20
Jun 20, 2021
M
Recruiting
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Laboratory Biomarker Analysis
  • Lenalidomide
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-16
Jun 16, 2021
O
Active, not recruiting
  • Demyelinating Sensorimotor Neuropathy
  • Lenalidomide
  • Ann Arbor, Michigan
  • +1 more
2021-11-03
Nov 3, 2021
H
Recruiting
  • Primary Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-01-30
Jan 30, 2021
W
Completed
  • Chronic Lymphocytic Leukemia
  • New York, New York
    Weill Cornell Medical College
2021-03-23
Mar 23, 2021